Intensity Therapeutics, Inc. (INTS) Live Share Price, Invest From India

Intensity Therapeutics, Inc. Stock Performance

as on September 4, 2026 at 2:05 am IST

Day's Low
Day's High
$4.03
Day's Price Range
$4.12
$4.09
1.47%
Downside
0.73%
Upside
52 Week's Low
52 Week's High
$3.51
52-Week Price Range
$43.50
$4.09
14.18%
Downside
963.57%
Upside

Intensity Therapeutics, Inc. share price movements today

Previous Close: $4.00
Open: $4.12
Volume: 11.2K
Market Cap: $13.3M
Day's Low - High: $4.03 - $4.12
52 Week Low - High: $3.51 - $43.50

Intensity Therapeutics, Inc. Historical Returns

1 Month Return: -1.93 %
3 Month Return: -4.91 %
1 Year Return: -40.8 %
3 Year Return: -97.12 %
5 Year Return: 0 %

Intensity Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Intensity Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.3M

EPS (TTM)

-4.83

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.01

Industry PE ratio

-1.4626335877862595

PEG Ratio

-0.00548184312157907

EBITDA

-8.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-116.61%

Intensity Therapeutics, Inc. Stock Valuation

Track how Intensity Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Intensity Therapeutics, Inc. in the last 5 years

Overview
Trends

Lowest (-11.15x)

December 31, 2023

Industry (-1.46x)

December 31, 2025

Today (-1.20x)

December 31, 2025

Highest (-1.20x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.20x

Intensity Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Intensity Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Intensity Therapeutics, Inc.	BUY	$13.3M	NA	-1.01	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$137.9B	174.9%	31.92	86.04%	NA
Moderna	BUY	$61.6B	-61.21%	-7.98	-12.57%	NA
Regeneron	BUY	$82.3B	21.91%	19.9	84.86%	0.44%

Stock Returns calculator for Intensity Therapeutics, Inc. Stock including INR - Dollar returns

The Intensity Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Intensity Therapeutics, Inc. investment value today

Current value as on today

₹63,815

Returns

-₹36,185

(-36.18%)

Returns from Intensity Therapeutics, Inc. Stock

-₹40,509 (-40.51%)

Dollar Impact

₹4,324 (+4.32%)

Analyst Recommendation on Intensity Therapeutics, Inc. Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Intensity Therapeutics, Inc.. Average target price of $19.33

Intensity Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Intensity Therapeutics, Inc..

What analysts predicted

78.84%UPSIDE

Target Price

$19.33

Current Price

$4.09

Analyzed by

2 Analysts

Target

$19.33

Intensity Therapeutics, Inc. target price $19.33, a slight upside of 78.84% compared to current price of $4.09. According to 2 analysts rating.

Indian Investors' Interest in Intensity Therapeutics, Inc. Stock

Search interest for Intensity Therapeutics, Inc. Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 4, 2026 to September 3, 2026

Change:-23% versus previous 30 day period

Intensity Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-	-	-	-	-	-	-	0	-
Operating Income	-4	-5	-3	-3	-3	-2	-2	-3	-2	-3
EBITDA	-4	-4	-3	-3	-3	-2	0	-3	-2	-3
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	-	0	-	2	0	-	-
Income Before Tax	-4	-4	-3	-3	-3	-2	-2	-3	-2	-3
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-4	-4	-3	-3	-3	-2	-2	-3	-2	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Intensity Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	0	-	0
Operating Income	-5	-6	-8	-7	-8	-16	-11
EBITDA	-5	-6	-7	-7	-10	-16	-11
Interest Expense	-	-	0	0	0	-	-
Depreciation	0	-	-	0	0	-	-
Income Before Tax	-5	-6	-7	-7	-10	-16	-11
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-5	-5	-7	-7	-10	-16	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Intensity Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-4	-4	-3	-3	-3	-2	-2	-3	-2	-3
Operating Cash Flow	-4	-4	-3	-2	-1	-2	-2	-2	-1	-2
Investing Cash Flow	3	0	3	-	-	-	-	-	-	-
Financing Cash Flow	0	0	0	2	0	3	7	7	0	1
Change in Cash	-1	-4	0	0	-1	1	4	4	-1	0

Intensity Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-6	-7	-7	-10	-16	-11
Operating Cash Flow	-4	-5	-6	-5	-7	-15	-9
Investing Cash Flow	1	4	-	-	-6	6	-
Financing Cash Flow	3	6	2	2	20	2	18
Change in Cash	1	5	-4	-3	7	-5	9

Mutual Funds that own Intensity Therapeutics, Inc. Stock

Check out the Mutual Funds with significant holdings in Intensity Therapeutics, Inc..

Funds	Holdings	Shares Held
Fidelity Concord Street Trust	0.519161%	16950
VANGUARD INDEX FUNDS	0.515823%	16841

Global Institutional Holdings in Intensity Therapeutics, Inc.

Funds	Holdings
Vanguard	0.81%

Insights on Intensity Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 527.1% return, outperforming this stock by 567.8%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 34.0% return, outperforming this stock by 131.2%
NEGATIVE IMPACT
Price Dip
In the last 6 months, INTS stock has moved down by -46.8%

About Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Organisation	Intensity Therapeutics, Inc.
Headquarters	1 Enterprise Drive, Shelton, CT, United States, 06484-4779
Industry	Biotechnology
CEO	Mr. Lewis H. Bender M.A., M.B.A., M.S.
E-voting on shares	Click here to vote

Key Management of Intensity Therapeutics, Inc.

Name	Title
Mr. Lewis H. Bender M.A., M.B.A., M.S.	Founder, President, CEO & Chairman of the Board
Mr. Joseph Talamo CPA, M.B.A.	Chief Financial Officer
Mr. John Wesolowski CPA, M.B.A.	Principal Accounting Officer & Controller
Mr. James M. Ahlers	Executive Vice President of Corporate Finance

FAQs

What is Intensity Therapeutics, Inc. share price today?

Intensity Therapeutics, Inc. share price today is $4.09 as on September 3, 2026 at 8:35 pm IST. Intensity Therapeutics, Inc. share today touched a day high of $4.12 and a low of $4.03.

What is the 52 week high and 52 week low for Intensity Therapeutics, Inc. share?

Intensity Therapeutics, Inc. share touched a 52 week high of $43.50 on October 30, 2025 and a 52 week low of $3.51 on June 9, 2026. Intensity Therapeutics, Inc. stock price today i.e. September 3, 2026 at 8:35 pm IST is trending at $4.09,which is 90.60% down from its 52 week high and 16.52% up from its 52 week low.

What is Intensity Therapeutics, Inc.'s market capitalisation today?

Intensity Therapeutics, Inc. market capitalisation is $0.00T as on September 3, 2026 at 8:35 pm IST.

How to invest in Intensity Therapeutics, Inc. Stock (INTS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Intensity Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Intensity Therapeutics, Inc. Shares that will get you 0.3667 shares as per Intensity Therapeutics, Inc. share price of $4.09 per share as on September 3, 2026 at 8:35 pm IST.

What is the minimum amount required to buy Intensity Therapeutics, Inc. Stock (INTS) from India?

Indian investors can start investing in Intensity Therapeutics, Inc. (INTS) shares with as little as ₹94.475 or $1 (as of September 3, 2026 at 8:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Intensity Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on September 3, 2026 at 8:39 pm IST). Based on Intensity Therapeutics, Inc. share’s latest price of $4.09 as on September 3, 2026 at 8:35 pm IST, you will get 2.4450 shares of Intensity Therapeutics, Inc.. Learn more about fractional shares .